Fidelity Investments
BSX icon

Fidelity Investments’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.6B Sell
108,310,577
-20,286,637
-16% -$2.18B 0.66% 20
2025
Q1
$13B Sell
128,597,214
-3,845,669
-3% -$388M 0.83% 15
2024
Q4
$11.8B Sell
132,442,883
-2,754,011
-2% -$246M 0.71% 18
2024
Q3
$11.3B Sell
135,196,894
-6,263,772
-4% -$525M 0.69% 16
2024
Q2
$10.9B Sell
141,460,666
-469,347
-0.3% -$36.1M 0.7% 17
2024
Q1
$9.72B Buy
141,930,013
+3,679,063
+3% +$252M 0.65% 20
2023
Q4
$7.99B Buy
138,250,950
+12,330,593
+10% +$713M 0.61% 21
2023
Q3
$6.65B Buy
125,920,357
+8,045,263
+7% +$425M 0.57% 23
2023
Q2
$6.38B Buy
117,875,094
+4,114,010
+4% +$223M 0.53% 23
2023
Q1
$5.69B Buy
113,761,084
+12,577,938
+12% +$629M 0.52% 23
2022
Q4
$4.68B Buy
101,183,146
+19,055,975
+23% +$882M 0.47% 29
2022
Q3
$3.18B Buy
82,127,171
+4,159,124
+5% +$161M 0.33% 44
2022
Q2
$2.91B Sell
77,968,047
-15,151,332
-16% -$565M 0.29% 55
2022
Q1
$4.12B Sell
93,119,379
-5,786,533
-6% -$256M 0.33% 40
2021
Q4
$4.2B Sell
98,905,912
-8,692,666
-8% -$369M 0.31% 44
2021
Q3
$4.67B Buy
107,598,578
+4,293,223
+4% +$186M 0.37% 36
2021
Q2
$4.42B Buy
103,305,355
+17,054,254
+20% +$729M 0.35% 40
2021
Q1
$3.33B Buy
86,251,101
+21,612,471
+33% +$835M 0.28% 52
2020
Q4
$2.32B Buy
64,638,630
+2,915,986
+5% +$105M 0.21% 79
2020
Q3
$2.36B Sell
61,722,644
-6,213,151
-9% -$237M 0.24% 71
2020
Q2
$2.39B Sell
67,935,795
-35,007,643
-34% -$1.23B 0.26% 63
2020
Q1
$3.36B Sell
102,943,438
-24,571,071
-19% -$802M 0.47% 34
2019
Q4
$5.77B Sell
127,514,509
-5,246,023
-4% -$237M 0.64% 20
2019
Q3
$5.4B Sell
132,760,532
-2,150,193
-2% -$87.5M 0.65% 20
2019
Q2
$5.8B Sell
134,910,725
-11,883,200
-8% -$511M 0.68% 18
2019
Q1
$5.63B Sell
146,793,925
-5,718,823
-4% -$219M 0.67% 18
2018
Q4
$5.39B Sell
152,512,748
-12,726,715
-8% -$450M 0.74% 19
2018
Q3
$6.36B Buy
165,239,463
+8,617,011
+6% +$332M 0.72% 21
2018
Q2
$5.12B Buy
156,622,452
+14,711,069
+10% +$481M 0.59% 25
2018
Q1
$3.88B Sell
141,911,383
-15,604,361
-10% -$426M 0.46% 26
2017
Q4
$3.9B Sell
157,515,744
-21,253,005
-12% -$527M 0.46% 29
2017
Q3
$5.21B Buy
178,768,749
+4,484,407
+3% +$131M 0.63% 22
2017
Q2
$4.83B Sell
174,284,342
-10,424,048
-6% -$289M 0.6% 21
2017
Q1
$4.59B Buy
184,708,390
+13,105,596
+8% +$326M 0.58% 21
2016
Q4
$3.71B Sell
171,602,794
-6,754,815
-4% -$146M 0.5% 28
2016
Q3
$4.24B Sell
178,357,609
-1,127,254
-0.6% -$26.8M 0.57% 24
2016
Q2
$4.19B Sell
179,484,863
-9,560,358
-5% -$223M 0.57% 24
2016
Q1
$3.56B Buy
189,045,221
+16,811,369
+10% +$316M 0.49% 34
2015
Q4
$3.18B Sell
172,233,852
-29,348,467
-15% -$541M 0.43% 38
2015
Q3
$3.31B Buy
201,582,319
+6,423,834
+3% +$105M 0.47% 33
2015
Q2
$3.45B Sell
195,158,485
-982,006
-0.5% -$17.4M 0.44% 34
2015
Q1
$3.48B Sell
196,140,491
-2,832,986
-1% -$50.3M 0.44% 35
2014
Q4
$2.64B Buy
198,973,477
+16,199,073
+9% +$215M 0.34% 52
2014
Q3
$2.16B Buy
182,774,404
+22,519,107
+14% +$266M 0.29% 64
2014
Q2
$2.05B Sell
160,255,297
-37,747,496
-19% -$482M 0.27% 69
2014
Q1
$2.68B Buy
198,002,793
+18,042,261
+10% +$244M 0.37% 50
2013
Q4
$2.16B Sell
179,960,532
-9,449,152
-5% -$114M 0.31% 59
2013
Q3
$2.22B Buy
189,409,684
+48,325,637
+34% +$567M 0.34% 57
2013
Q2
$1.31B Buy
+141,084,047
New +$1.31B 0.21% 97